Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest versus levonorgestrel IUD for symptomatic uterine fibroids
PACTR202506543835976Not yet recruiting
- Sponsor
- Helwan University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dienogest and avatrombopag in Fibromyoma (LM) (2 arms), sponsored by Helwan University. Primary endpoint: Uterine myoma size. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
dienogestavatrombopag
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202506543835976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506543835976.